2 completed. 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow lanpol 5: new trials by email Literature Review of lanpol 5 trials Research Report on lanpol 5
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Single-Center, Exploratory Study to Analyze the Dynamics of Skin Microflora Following Exposure to Surfactants PEG-40 Hydrogenated Castor Oil (Tagat CH40, Evonik) 1.5%, Lauryl glucoside (Plantacare® 1200UP, BASF) 1.5%, Sorbitan palmitate (SPANTM 40 (powder), Croda) 1.5% - Dermatitis | Not applicable | Completed | Kimberly-Clark Corporation | 24 | 2015-11-01 | 2016-09-28 |
| Botanical Oil Supplementation in Diabetic and Metabolic Syndrome Subjects borage/echium oil combination, fish oil, corn oil - Diabetes, Metabolic Syndrome x | Phase 2 | Completed | Wake Forest University Health Sciences | 80 | 2009-05-01 | 2019-07-18 |
Dermatitis (1) · Diabetes Mellitus (1) · Inflammation (1) · Metabolic Syndrome (1)
Kimberly-Clark Corporation (1) · Wake Forest University Health Sciences (1)
United States (2)
Barry Reece, MBA (1)